Literature DB >> 6811681

Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity.

C H Chen, J J Albers.   

Abstract

Proteoliposome vesicles containing apoA-I, lecithin, and cholesterol (including labeled cholesterol) were prepared from various molar ratios of the three components by the cholate dialysis technique. Comparative studies on the sensitivity and efficiency of these proteoliposomes to serve as substrate for lecithin:cholesterol acyltransferase (LCATase) indicated that the proteoliposome with apoA-I:lecithin:cholesterol molar ratio of 0.8:250:12.5 was ideal for assaying LCATase activity of both plasma and purified enzyme. This proteoliposome was shown to be comparable in size by gel filtration (radius, 131.9 +/- 4.8 A, n = 6) and by electron microscopy (radius, 123.4 +/- 5.1 A, n = 100). The proteoliposome preparation was stable as LCATase substrate for at least 3 and 5 weeks, respectively, when stored at 4 degrees C and -20 degrees C, and was a better substrate for the enzyme activity assay than were lecithin-cholesterol liposomes incubated with apoA-I. Under the standardized assay system LCATase activity was a linear function of plasma enzyme added and was independent of the amount of plasma cholesterol added to the proteoliposomes in the range of 3 to 20 microliters of plasma. The mean LCATase activity by this method was 95.1 +/- 14.0 (range 76.5-122.5) nmol/hr per ml of plasma from fifteen normal human subjects. This method of substrate formation using the cholate dialysis technique permits the preparation of large amounts of stable, efficient, homogeneous, and well-defined substrate that is suitable for measuring low levels of enzyme activity, comparative studies, and large scale investigations of plasma LCATase, as well as studies of the mechanism and regulation of LCATase reaction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811681

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  41 in total

1.  Purification of an apolipoprotein A binding protein from mouse adipose cells.

Authors:  R Barbaras; P Puchois; J C Fruchart; A Pradines-Figueres; G Ailhaud
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

2.  Protection of membrane cholesterol by sphingomyelin against free radical-mediated oxidation.

Authors:  Robert M Sargis; Papasani V Subbaiah
Journal:  Free Radic Biol Med       Date:  2006-02-28       Impact factor: 7.376

3.  Reverse cholesterol transport is regulated by varying fatty acyl chain saturation and sphingomyelin content in reconstituted high-density lipoproteins.

Authors:  Philippe Marmillot; Sanket Patel; M Raj Lakshman
Journal:  Metabolism       Date:  2007-02       Impact factor: 8.694

4.  Spontaneous healing of Langerhans cell histiocytosis (histiocytosis X).

Authors:  L Corbeel; E Eggermont; J Desmyter; I Surmont; R De Vos; C De Wolf-Peeters; C Cobbaert; A Eykens
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

5.  Differential effects of conjugated linoleic acid isomers on the biophysical and biochemical properties of model membranes.

Authors:  Papasani V Subbaiah; Debajit Sircar; Buzulagu Aizezi; Evan Mintzer
Journal:  Biochim Biophys Acta       Date:  2009-12-11

6.  Effect of double bond geometry in sphingosine base on the antioxidant function of sphingomyelin.

Authors:  Papasani V Subbaiah; Debajit Sircar; Ravi S Lankalapalli; Robert Bittman
Journal:  Arch Biochem Biophys       Date:  2008-10-12       Impact factor: 4.013

7.  Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.

Authors:  K Satoh; T Imaizumi; Y Kawamura; H Yoshida; M Hiramoto; S Takamatsu; M Takamatsu
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

8.  Decreased activity of lecithin:cholesterol acyltransferase and hepatic lipase in chronic hypothyroid rats: implications for reverse cholesterol transport.

Authors:  Martha Franco; Graciela Castro; Luis Romero; Juan Carlos Regalado; Aida Medina; Claudia Huesca-Gómez; Serafín Ramírez; Luis F Montaño; Carlos Posadas-Romero; Oscar Pérez-Méndez
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

9.  Increased lysolecithin acyltransferase activity in the plasma of type II hyperlipoproteinemic patients.

Authors:  P V Subbaiah; J T Ogilvie
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

10.  Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis.

Authors:  H G Klein; S Santamarina-Fojo; N Duverger; M Clerc; M F Dumon; J J Albers; S Marcovina; H B Brewer
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.